| NCT05920135 | First-in-Human Study of BBT-207 in Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation After Treatment With EGFR TKI | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2023-09-11 | 2028-08-01 | 2026-08-01 |
| NCT05483907 | To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF | COMPLETED | PHASE2 | 2023-04-12 | 2025-02-23 | 2025-01-26 |
| NCT04596293 | Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis | COMPLETED | PHASE2 | 2021-06-11 | 2022-07-12 | 2022-05-17 |
| NCT04478825 | Efficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative Colitis | TERMINATED | PHASE1 | 2021-06-01 | 2021-08-24 | 2021-08-04 |
| NCT04820023 | Phase 1/2 Study of BBT-176 in Advanced NSCLC With Progression After EGFR TKI Treatment | TERMINATED | PHASE1, PHASE2 | 2021-04-02 | 2023-11-29 | 2023-11-29 |
| NCT04138849 | Evaluate Safety, Pharmacokinetics and Pharmacodynamics of BBT-877 in Healthy Japanese Male | COMPLETED | PHASE1 | 2019-10-01 | 2019-10-25 | 2019-10-25 |
| NCT04138836 | Assess the Drug Interactions of BBT-877 and Midazolam, Itraconazole, and Esomeprazole in Healthy Adult Subjects | COMPLETED | PHASE1 | 2019-09-17 | 2019-11-04 | 2019-11-04 |
| NCT03800420 | Efficacy and Safety of BBT-401-1S in Ulcerative Colitis | TERMINATED | PHASE2 | 2019-04-22 | 2020-07-31 | 2020-05-18 |
| NCT03830125 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 in Healthy Subjects | COMPLETED | PHASE1 | 2019-02-13 | 2019-11-24 | 2019-11-24 |
| NCT03482648 | First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Volunteers | COMPLETED | PHASE1 | 2018-03-20 | 2018-10-03 | 2018-09-26 |
| NCT01342497 | Oral BBR-012 in the Treatment of Diabetic Foot Ulcers, Proof of Concept Study | UNKNOWN | PHASE2 | 2011-07 | 2012-08 | 2012-08 |